559 related articles for article (PubMed ID: 34059747)
1. Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.
Inoue M; Matsumoto K; Tanaka M; Yoshida Y; Satake R; Goto F; Shimada K; Mukai R; Hasegawa S; Suzuki T; Ikesue H; Liao J; Hashida T; Nakamura M
Sci Rep; 2021 May; 11(1):11324. PubMed ID: 34059747
[TBL] [Abstract][Full Text] [Related]
2. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
[TBL] [Abstract][Full Text] [Related]
3. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials.
Kishimoto S; Oshima N; Rinker M; Krishna MC; Takebe N
Eur J Cancer; 2019 Jul; 115():111-119. PubMed ID: 31132741
[TBL] [Abstract][Full Text] [Related]
4. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
Ibrahim EY; Ehrlich BE
Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.
Kobayashi A; Ikemura K; Wakai E; Kondo M; Okuda M
Anticancer Res; 2023 Dec; 43(12):5613-5620. PubMed ID: 38030205
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
Yokoyama S; Nakagawa C; Hosomi K
Support Care Cancer; 2022 Feb; 30(2):1765-1773. PubMed ID: 34595605
[TBL] [Abstract][Full Text] [Related]
9. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
[TBL] [Abstract][Full Text] [Related]
10. Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.
Stage TB; Hu S; Sparreboom A; Kroetz DL
Clin Transl Sci; 2021 Mar; 14(2):460-467. PubMed ID: 33142018
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer.
Guo Q; Zhang H; Li X; Quan X
Biomed Res Int; 2022; 2022():9430952. PubMed ID: 36147633
[TBL] [Abstract][Full Text] [Related]
12. Innovative Approach for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Pilot Study With the Hilotherm Device, the Poliambulanza Hospital Experience.
Oneda E; Meriggi F; Zanotti L; Zaina E; Bighè S; Andreis F; Rueda S; Zaniboni A
Integr Cancer Ther; 2020; 19():1534735420943287. PubMed ID: 32856475
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
15. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
16. Management of peripheral neuropathy induced by nab-paclitaxel treatment for breast cancer.
Ohno T; Mine T; Yoshioka H; Kosaka M; Matsuda S; De Kerckhove M; De Kerckhove C; Irie J; Inoue K; Haraguchi M; Kitajima M; Shinichiro I; Tokai H; Tanaka T; Izumida R
Anticancer Res; 2014 Aug; 34(8):4213-6. PubMed ID: 25075049
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
18. [Nursing care of chemotherapy-induced peripheral neuropathy].
Hsu SY; Lu CH; Chen SZ; Jane SW
Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
[TBL] [Abstract][Full Text] [Related]
19. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced peripheral neuropathy.
Fehrenbacher JC
Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
